Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series.

Leuk Lymphoma

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Published: December 2021

Download full-text PDF	Source
http://dx.doi.org/10.1080/10428194.2021.1957876	DOI Listing

Publication Analysis

venetoclax combined

combined azacitidine

azacitidine effective

effective safe

safe salvage

salvage regimen

regimen relapsed

relapsed refractory

refractory t-cell

t-cell acute

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!